Insulin and Insulin-like growth factor-1 can activate the phosphoinositide-3-kinase /Akt/FoxO1 pathway in T cells in vitro

References

• Taylor M, Gonzalez M, Porter R. Pathways to inflammation: Acne pathophysiology. Eur J Dermatol. 2011;21:323-33. doi:10.1684/ejd.2011.1357. PMID:21609898
   PubMed Web of Science ®Google Scholar
• Do TT, Zarkhin S, Orringer JS, Nemeth S, Hamilton T, Sachs D, Voorhees JJ, Kang S. Computer-assisted alignment and tracking of acne lesions indicate that most inflammatory lesions arise from comedones and de novo. J Am Acad Dermatol. 2008;58:603-8. doi:10.1016/j.jaad.2007.12.024. PMID:18249468
   PubMed Web of Science ®Google Scholar
• Tochio T, Tanaka H, Nakata S, Ikeno H. Accumulation of lipid peroxide in the content of comedones may be involved in the progression of comedogenesis and inflammatory changes in comedones. J Cosmet Dermatol. 2009;8:152-8. doi:10.1111/j.1473-2165.2009.00437.x. PMID:19527342
   PubMed Web of Science ®Google Scholar
• Tanghetti EA. The role of inflammation in the pathology of acne. J Clin Aesthet Dermatol. 2013;6:27. PMID:24062871
   PubMedGoogle Scholar
• Shehadeh N, Kligman AM. The bacteriology of acne. Arch Dermatol. 1963;88:829-31. doi:10.1001/archderm.1963.01590240153025. PMID:14071456
   PubMedGoogle Scholar
• Marples RR, Mcginley KJ, Mills OH. Microbiology of comedones in acne vulgaris. J Invest Dermatol. 1973;60:80-3. doi:10.1111/1523-1747.ep12724149. PMID:4266324
   PubMed Web of Science ®Google Scholar
• Puhvel S, AMIRIAN DA. Bacterial flora of comedones. Br J Dermatol. 1979;101:543-8. doi:10.1111/j.1365-2133.1979.tb11883.x. PMID:160242
   PubMed Web of Science ®Google Scholar
• Shaheen B, Gonzalez M. A microbial aetiology of acne: what is the evidence? Br J Dermatol. 2011;165:474-85. doi:10.1111/j.1365-2133.2011.10375.x. PMID:21495996
   PubMed Web of Science ®Google Scholar
• Boehm KD, Yun JK, StrohI KP, Elmets CA. Messenger RNAs for the multifunctional cytokines interleukin‐1α, interleukin‐1β and tumor necrosis factor‐α are present in adnexal tissues and in dermis of normal human skin. Exp Dermatol. 1995;4:335-41. doi:10.1111/j.1600-0625.1995.tb00057.x. PMID:8608340
   PubMedGoogle Scholar
• Anttila H, Reitamo S, SAURAT JH. Interleukin 1 immunoreactivity in sebaceous glands. Br J Dermatol. 1992;127:585-8. doi:10.1111/j.1365-2133.1992.tb14870.x. PMID:1476918
   PubMed Web of Science ®Google Scholar
• Das S, Reynolds RV. Recent advances in acne pathogenesis: Implications for therapy. Am J Clin Dermatol. 2014;15:479-88. doi:10.1007/s40257-014-0099-z. PMID:25388823
   PubMed Web of Science ®Google Scholar
• Mirdamadi Y, Thielitz A, Wiede A, Goihl A, Papakonstantinou E, Hartig R, Zouboulis CC, Reinhold D, Simeoni L, Bommhardt U. Insulin and insulin-like growth factor-1 can modulate the phosphoinositide-3-kinase/Akt/FoxO1 pathway in SZ95 sebocytes in vitro. Mol Cell Endocrinol. 2015;415:32-44. doi:10.1016/j.mce.2015.08.001. PMID:26257240
   PubMed Web of Science ®Google Scholar
• Kurokawa I, Danby FW, Ju Q, Wang X, Xiang LF, Xia L, Chen W, Nagy I, Picardo M, Suh DH. New developments in our understanding of acne pathogenesis and treatment. Exp Dermatol. 2009;18:821-32. doi:10.1111/j.1600-0625.2009.00890.x. PMID:19555434
   PubMed Web of Science ®Google Scholar
• Dreno B, Gollnick H, Kang S, Thiboutot D, Bettoli V, Torres V, Leyden J. Understanding innate immunity and inflammation in acne: Implications for management. J Eur Acad Dermatol Venereol. 2015;29:3-11. doi:10.1111/jdv.13190. PMID:26059728
   PubMed Web of Science ®Google Scholar
• Gollnick H, Dreno B. Pathophysiology and management of acne. Journal of the European J Eur Acad Dermatol Venereol. 2015;29:1-2. doi:10.1111/jdv.13190. PMID:26059728
   PubMed Web of Science ®Google Scholar
• Clark RA. Skin-resident T cells: The ups and downs of on site immunity. J Invest Dermatol. 2010;130:362-70. doi:10.1038/jid.2009.247. PMID:19675575
   PubMed Web of Science ®Google Scholar
• Lorenz B, von Stebut E. Isolation of T Cells from the Skin. Methods Mol Biol. 2014:3-13. doi:10.1007/978-1-4939-1212-4_1. PMID:25150991
   PubMedGoogle Scholar
• Norris J, Cunliffe W. A histological and immunocytochemical study of early acne lesions. Br J Dermatol. 1988;118:651-9. doi:10.1111/j.1365-2133.1988.tb02566.x. PMID:2969256
   PubMed Web of Science ®Google Scholar
• Layton A, Morris C, Cunliffe W, Ingham E. Immunohistochemical investigation of evolving inflammation in lesions of acne vulgaris. Exp Dermatol. 1998;7:191-7. doi:10.1111/j.1600-0625.1998.tb00323.x. PMID:9758417
   PubMed Web of Science ®Google Scholar
• Jeremy AH, Holland DB, Roberts SG, Thomson KF, Cunliffe WJ. Inflammatory events are involved in acne lesion initiation. J Invest Dermatol. 2003;121:20-7. doi:10.1046/j.1523-1747.2003.12321.x. PMID:12839559
   PubMed Web of Science ®Google Scholar
• Cordain L, Lindeberg S, Hurtado M, Hill K, Eaton SB, Brand-Miller J. Acne vulgaris: A disease of Western civilization. Arch Dermatol. 2002;138:1584-90. doi:10.1001/archderm.138.12.1584. PMID:12472346
   PubMed Web of Science ®Google Scholar
• Cordain L, Eades MR, Eades MD. Hyperinsulinemic diseases of civilization: more than just Syndrome X. Comp Biochem Physiol A Mol Integr Physiol. 2003;136:95-112. doi:10.1016/S1095-6433(03)00011-4. PMID:14527633
   PubMed Web of Science ®Google Scholar
• Cappel M, Mauger D, Thiboutot D. Correlation between serum levels of insulin-like growth factor 1, dehydroepiandrosterone sulfate, and dihydrotestosterone and acne lesion counts in adult women. Arch Dermatol. 2005;141:333-8. doi:10.1001/archderm.141.3.333. PMID:15781674
   PubMed Web of Science ®Google Scholar
• Melnik BC, Schmitz G. Role of insulin, insulin‐like growth factor‐1, hyperglycaemic food and milk consumption in the pathogenesis of acne vulgaris. Exp Dermatol. 2009;18:833-41. doi:10.1111/j.1600-0625.2009.00924.x. PMID:19709092
   PubMed Web of Science ®Google Scholar
• Vora S, Ovhal A, Jerajani H, Nair N, Chakrabortty A. Correlation of facial sebum to serum insulin-like growth factor-1 in patients with acne. Br J Dermatol. 2008;159:990-1. doi:10.1111/j.1365-2133.2008.08764.x. PMID:18652583
   PubMed Web of Science ®Google Scholar
• LaRosa CL, Quach KA, Koons K, Kunselman AR, Zhu J, Thiboutot DM, Zaenglein AL. Consumption of dairy in teenagers with and without acne. J Am Acad Dermatol. 2016;75:318-22. doi:10.1016/j.jaad.2016.04.030. PMID:27241803
   PubMed Web of Science ®Google Scholar
• Melnik BC. FoxO1–the key for the pathogenesis and therapy of acne? J Dtsch Dermatol Ges. 2010;8:105-14. doi:10.1111/j.1610-0387.2010.07344.x. PMID:20151947
   PubMed Web of Science ®Google Scholar
• Coffer PJ, Burgering BM. Forkhead-box transcription factors and their role in the immune system. Nat Rev Immunol. 2004;4:889-99. doi:10.1038/nri1488. PMID:15516968
   PubMed Web of Science ®Google Scholar
• Birkenkamp KU, Coffer PJ. FOXO transcription factors as regulators of immune homeostasis: molecules to die for? J Immunol. 2003;171:1623-9. doi:10.4049/jimmunol.171.4.1623. PMID:12902457
   PubMed Web of Science ®Google Scholar
• Helderman JH, Strom TB. Specific insulin binding site on T and B lymphocytes as a marker of cell activation. Nature. 1978;274:62. doi:10.1038/274062a0. PMID:26882
   PubMed Web of Science ®Google Scholar
• Kooijman R, Scholtens L, Rijkers G, Zegers B. Type I insulin-like growth factor receptor expression in different developmental stages of human thymocytes. J Endocrinol. 1995;147:203-9. doi:10.1677/joe.0.1470203. PMID:7490549
   PubMed Web of Science ®Google Scholar
• Kooijman R, Scholtens LE, Rijkers GT, Zegers BJ. Differential expression of type I insulin‐like growth factor receptors in different stages of human T cells. Eur J Immunol. 1995;25:931-5. doi:10.1002/eji.1830250411. PMID:7737296
   PubMed Web of Science ®Google Scholar
• Braciale VL, Gavin J, Braciale TJ. Inducible expression of insulin receptors on T lymphocyte clones. J Exp Med. 1982;156:664-9. doi:10.1084/jem.156.2.664. PMID:7047673
   PubMed Web of Science ®Google Scholar
• DeBenedette M, Snow E. Insulin modulates the interleukin 2 responsiveness of T lymphocytes. Reg Immunol. 1990;3:82-7. PMID:2150918
   PubMedGoogle Scholar
• Brocardo MG, Schillaci R, Galeano A, Radrizzani M, White V, Guerrico AG, Santa-Coloma TA, Roldán A. Early effects of insulin-like growth factor-1 in activated human T lymphocytes. J Leukoc Biol. 2001;70:297-305. PMID:11493623
   PubMed Web of Science ®Google Scholar
• Kecha O, Brilot F, Martens H, Franchimont N, Renard C, Greimers R, Defresne M-P, Winkler R, Geenen V. Involvement of Insulin-Like Growth Factors in Early T Cell Development: A Study Using Fetal Thymic Organ Cultures 1. Endocrinology. 2000;141:1209-17. doi:10.1210/endo.141.3.7360. PMID:10698198
   PubMed Web of Science ®Google Scholar
• Fabre S, Lang V, Harriague J, Jobart A, Unterman TG, Trautmann A, Bismuth G. Stable activation of phosphatidylinositol 3-kinase in the T cell immunological synapse stimulates Akt signaling to FoxO1 nuclear exclusion and cell growth control. J Immunol. 2005;174:4161-71. doi:10.4049/jimmunol.174.7.4161. PMID:15778376
   PubMed Web of Science ®Google Scholar
• Charvet C, Canonigo AJ, Bécart S, Maurer U, Miletic AV, Swat W, Deckert M, Altman A. Vav1 promotes T cell cycle progression by linking TCR/CD28 costimulation to FOXO1 and p27kip1 expression. J Immunol. 2006;177:5024-31. doi:10.4049/jimmunol.177.8.5024. PMID:17015685
   PubMed Web of Science ®Google Scholar
• Walsh PT, Smith LM, O'Connor R. Insulin‐like growth factor‐1 activates Akt and Jun N‐terminal kinases (JNKs) in promoting the survival of T lymphocytes. Immunology. 2002;107:461-71. doi:10.1046/j.1365-2567.2002.01525.x. PMID:12460191
   PubMed Web of Science ®Google Scholar
• Han JM, Patterson SJ, Speck M, Ehses JA, Levings MK. Insulin Inhibits IL-10–Mediated Regulatory T Cell Function: Implications for Obesity. J Immunol. 2014;192:623-9.doi:10.4049/jimmunol.1302181. PMID:24323581
   PubMed Web of Science ®Google Scholar
• Inoki K, Ouyang H, Li Y, Guan K-L. Signaling by target of rapamycin proteins in cell growth control. Microbiol Mol Biol Rev. 2005;69:79-100. doi:10.1128/MMBR.69.1.79-100.2005. PMID:15755954
   PubMed Web of Science ®Google Scholar
• Wang X, Proud CG. Nutrient control of TORC1, a cell-cycle regulator. Trends Cell Biol. 2009;19:260-7. doi:10.1016/j.tcb.2009.03.005. PMID:19419870
   PubMed Web of Science ®Google Scholar
• Suzuki T, Inoki K. Spatial regulation of the mTORC1 system in amino acids sensing pathway. Acta Biochim Biophys Sin (Shanghai). 2011;43:671-9. doi:10.1093/abbs/gmr066. PMID:21785113
   PubMed Web of Science ®Google Scholar
• Wang X, Proud CG. mTORC1 signaling: what we still don't know. J Mol Cell Biol. 2010;3(4):206–220. doi:10.1093/jmcb/mjq038. PMID:21138990
   PubMed Web of Science ®Google Scholar
• Monfrecola G, Lembo S, Caiazzo G, De Vita V, Di Caprio R, Balato A, Fabbrocini G. Mechanistic target of rapamycin (mTOR) expression is increased in acne patients' skin. Exp Dermatol. 2016;25:153-5. doi:10.1111/exd.12885. PMID:26477999
   PubMed Web of Science ®Google Scholar
• Pierdominici M, Vacirca D, Delunardo F, Ortona E. mTOR signaling and metabolic regulation of T cells: New potential therapeutic targets in autoimmune diseases. Curr Pharm Des. 2011;17:3888-97. doi:10.2174/138161211798357809. PMID:21933144
   PubMed Web of Science ®Google Scholar
• Powell JD, Pollizzi KN, Heikamp EB, Horton MR. Regulation of immune responses by mTOR. Annu Rev Immunol. 2012;30:39-68. doi:10.1146/annurev-immunol-020711-075024. PMID:22136167
   PubMed Web of Science ®Google Scholar
• Yang K, Chi H. mTOR and metabolic pathways in T cell quiescence and functional activation. Semin Immunol. 2012:421-8.doi:10.1016/j.smim.2012.12.004. PMID:23375549
   PubMed Web of Science ®Google Scholar
• Almeida L, Lochner M, Berod L, Sparwasser T. Metabolic pathways in T cell activation and lineage differentiation. Semin Immunol. 2016:514-24. doi:10.1016/j.smim.2016.10.009. PMID:27825556
   PubMed Web of Science ®Google Scholar
• Reynolds LF, Smyth LA, Norton T, Freshney N, Downward J, Kioussis D, Tybulewicz VL. Vav1 transduces T cell receptor signals to the activation of phospholipase C-γ1 via phosphoinositide 3-kinase-dependent and-independent pathways. J Exp Med. 2002;195:1103-14. doi:10.1084/jem.20011663. PMID:11994416
   PubMed Web of Science ®Google Scholar
• Na S-Y, Patra A, Scheuring Y, Marx A, Tolaini M, Kioussis D, Hemmings B, Hünig T, Bommhardt U. Constitutively active protein kinase B enhances Lck and Erk activities and influences thymocyte selection and activation. J Immunol. 2003;171:1285-96. doi:10.4049/jimmunol.171.3.1285. PMID:12874217
   PubMed Web of Science ®Google Scholar
• Janeway Jr CA, Medzhitov R. Innate immune recognition. Annu Rev Immunol. 2002;20:197-216. doi:10.1146/annurev.immunol.20.083001.084359. PMID:11861602
   PubMed Web of Science ®Google Scholar
• MacLeod H, Wetzler LM. T cell activation by TLRs: a role for TLRs in the adaptive immune response. Sci STKE. 2007;2007:pe48-pe.
   PubMedGoogle Scholar
• Komai-Koma M, Jones L, Ogg GS, Xu D, Liew FY. TLR2 is expressed on activated T cells as a costimulatory receptor. Proc Natl Acad Sci U S A. 2004;101:3029-34. doi:10.1073/pnas.0400171101. PMID:14981245
   PubMed Web of Science ®Google Scholar
• Mercier BC, Cottalorda A, Coupet C-A, Marvel J, Bonnefoy-Bérard N. TLR2 engagement on CD8 T cells enables generation of functional memory cells in response to a suboptimal TCR signal. J Immunol. 2009;182:1860-7. doi:10.4049/jimmunol.0801167. PMID:19201838
   PubMed Web of Science ®Google Scholar
• Reynolds JM, Martinez GJ, Chung Y, Dong C. Toll-like receptor 4 signaling in T cells promotes autoimmune inflammation. Proc Natl Acad Sci U S A. 2012;109:13064-9. doi:10.1073/pnas.1120585109. PMID:22826216
   PubMed Web of Science ®Google Scholar
• Arbibe L, Mira JP, Teusch N, Kline L, Guha M, Mackman N, Godowski PJ, Ulevitch RJ, Knaus UG. Toll-like receptor 2-mediated NF-kappa B activation requires a Rac1-dependent pathway. Nat Immunol. 2000;1:533-40. doi:10.1038/82797. PMID:11101877
   PubMed Web of Science ®Google Scholar
• Laird MH, Rhee SH, Perkins DJ, Medvedev AE, Piao W, Fenton MJ, Vogel SN. TLR4/MyD88/PI3K interactions regulate TLR4 signaling. J Leukoc Biol. 2009;85:966-77. doi:10.1189/jlb.1208763. PMID:19289601
   PubMed Web of Science ®Google Scholar
• Li X, Jiang S, Tapping RI. Toll-like receptor signaling in cell proliferation and survival. Cytokine. 2010;49:1-9. doi:10.1016/j.cyto.2009.08.010. PMID:19775907
   PubMed Web of Science ®Google Scholar
• Ojaniemi M, Glumoff V, Harju K, Liljeroos M, Vuori K, Hallman M. Phosphatidylinositol 3-kinase is involved in Toll-like receptor 4-mediated cytokine expression in mouse macrophages. Eur J Immunol. 2003;33:597-605. doi:10.1002/eji.200323376. PMID:12616480
   PubMed Web of Science ®Google Scholar
• Hazeki K, Nigorikawa K, Hazeki O. Role of phosphoinositide 3-kinase in innate immunity. Biol Pharm Bull. 2007;30:1617-23. doi:10.1248/bpb.30.1617. PMID:17827709
   PubMed Web of Science ®Google Scholar
• Martinasso G, Oraldi M, Trombetta A, Maggiora M, Bertetto O, Canuto R, Muzio G. Involvement of PPARs in cell proliferation and apoptosis in human colon cancer specimens and in normal and cancer cell lines. PPAR Res. 2007;2007:93416. doi:10.1155/2007/93416. PMID:17389773
   PubMed Web of Science ®Google Scholar
• Fan W, Imamura T, Sonoda N, Sears DD, Patsouris D, Kim JJ, Olefsky JM. FOXO1 transrepresses peroxisome proliferator-activated receptor γ transactivation, coordinating an insulin-induced feed-forward response in adipocytes. J Biol Chem. 2009;284:12188-97. doi:10.1074/jbc.M808915200. PMID:19246449
   PubMed Web of Science ®Google Scholar
• Fan W, Yanase T, Morinaga H, Okabe T, Nomura M, Daitoku H, Fukamizu A, Kato S, Takayanagi R, Nawata H. Insulin-like growth factor 1/insulin signaling activates androgen signaling through direct interactions of Foxo1 with androgen receptor. J Biol Chem. 2007;282:7329-38. doi:10.1074/jbc.M610447200. PMID:17202144
   PubMed Web of Science ®Google Scholar
• Chen W, Yang CC, Sheu HM, Seltmann H, Zouboulis CC. Expression of peroxisome proliferator-activated receptor and CCAAT/enhancer binding protein transcription factors in cultured human sebocytes. J Invest Dermatol. 2003;121:441-7. doi:10.1046/j.1523-1747.2003.12411.x. PMID:12925198
   PubMed Web of Science ®Google Scholar